Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Bayshore Medical Center
mi
from
Pasadena, TX
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Bayshore Medical Center
mi
from
Pasadena, TX
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Dixie Regional Medical Center
mi
from
Saint George, UT
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Dixie Regional Medical Center
mi
from
Saint George, UT
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
LDS Hospital
mi
from
Salt Lake City, UT
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
LDS Hospital
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Green Mountain Oncology Group
mi
from
Rutland, VT
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Green Mountain Oncology Group
mi
from
Rutland, VT
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Veterans Affairs Medical Center - White River Junction
mi
from
White River Junction, VT
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Veterans Affairs Medical Center - White River Junction
mi
from
White River Junction, VT
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Martha Jefferson Hospital
mi
from
Charlottesville, VA
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Martha Jefferson Hospital
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Cancer Center, University of Virginia HSC
mi
from
Charlottesville, VA
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Cancer Center, University of Virginia HSC
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Virginia Baptist Hospital
mi
from
Lynchburg, VA
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Virginia Baptist Hospital
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Naval Medical Center - Portsmouth
mi
from
Portsmouth, VA
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Naval Medical Center - Portsmouth
mi
from
Portsmouth, VA
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Massey Cancer Center
mi
from
Richmond, VA
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Massey Cancer Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Swedish Hospital Tumor Institute
mi
from
Seattle, WA
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Swedish Hospital Tumor Institute
mi
from
Seattle, WA
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Virginia Mason Medical Center
mi
from
Seattle, WA
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Virginia Mason Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Deaconess Medical Center
mi
from
Spokane, WA
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Deaconess Medical Center
mi
from
Spokane, WA
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Yakima Valley Memorial Hospital
mi
from
Yakima, WA
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Yakima Valley Memorial Hospital
mi
from
Yakima, WA
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Schiffler Oncology Center
mi
from
Wheeling, WV
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Schiffler Oncology Center
mi
from
Wheeling, WV
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
St. Vincent Hospital
mi
from
Green Bay, WI
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
St. Vincent Hospital
mi
from
Green Bay, WI
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Gundersen Lutheran Medical Foundation, Inc
mi
from
La Crosse, WI
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Gundersen Lutheran Medical Foundation, Inc
mi
from
La Crosse, WI
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Veterans Affairs Medical Center - Madison
mi
from
Madison, WI
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Veterans Affairs Medical Center - Madison
mi
from
Madison, WI
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Southern Wisconsin Radiotherapy Center
mi
from
Madison, WI
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Southern Wisconsin Radiotherapy Center
mi
from
Madison, WI
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
University of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
University of Wisconsin Comprehensive Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Marshfield Clinic
mi
from
Marshfield, WI
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Marshfield Clinic
mi
from
Marshfield, WI
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Community Memorial Hospital
mi
from
Menomonee Falls, WI
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Community Memorial Hospital
mi
from
Menomonee Falls, WI
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
St. Joseph's Hospital
mi
from
Milwaukee, WI
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
St. Joseph's Hospital
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Columbia Hospital
mi
from
Milwaukee, WI
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Columbia Hospital
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
St. Luke's Medical Center
mi
from
Milwaukee, WI
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
St. Luke's Medical Center
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Medical College of Wisconsin
mi
from
Milwaukee, WI
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Veterans Affairs Medical Center - Milwaukee (Zablocki)
mi
from
Milwaukee, WI
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Veterans Affairs Medical Center - Milwaukee (Zablocki)
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Southeastern Wisconsin Regional Cancer Center
mi
from
Racine, WI
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Southeastern Wisconsin Regional Cancer Center
mi
from
Racine, WI
Click here to add this to my saved trials
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated:  6/27/2016
Tom Baker Cancer Center - Calgary
mi
from
Calgary,
Talc in Treating Patients With Malignant Pleural Effusion
Sclerosis of Pleural Effusions by Talc Thoracoscopy Versus Talc Slurry: A Phase III Study
Status: Enrolling
Updated: 6/27/2016
Tom Baker Cancer Center - Calgary
mi
from
Calgary,
Click here to add this to my saved trials
Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer
A PHASE III TWO-ARM RANDOMIZED STUDY COMPARING ANTIANDROGEN WITHDRAWAL ALONE VERSUS ANTIANDROGEN WITHDRAWAL COMBINED WITH KETOCONAZOLE AND HYDROCORTISON IN PATIENTS WITH ADVANCED PROSTAGE CANCER
Status: Enrolling
Updated:  6/27/2016
UCSF Cancer Center and Cancer Research Institute
mi
from
San Francisco, CA
Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer
A PHASE III TWO-ARM RANDOMIZED STUDY COMPARING ANTIANDROGEN WITHDRAWAL ALONE VERSUS ANTIANDROGEN WITHDRAWAL COMBINED WITH KETOCONAZOLE AND HYDROCORTISON IN PATIENTS WITH ADVANCED PROSTAGE CANCER
Status: Enrolling
Updated: 6/27/2016
UCSF Cancer Center and Cancer Research Institute
mi
from
San Francisco, CA
Click here to add this to my saved trials
Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer
A PHASE III TWO-ARM RANDOMIZED STUDY COMPARING ANTIANDROGEN WITHDRAWAL ALONE VERSUS ANTIANDROGEN WITHDRAWAL COMBINED WITH KETOCONAZOLE AND HYDROCORTISON IN PATIENTS WITH ADVANCED PROSTAGE CANCER
Status: Enrolling
Updated:  6/27/2016
University of Minnesota Cancer Center
mi
from
Minneapolis, MN
Antiandrogen Withdrawal in Treating Patients With Hormone-Refractory Prostate Cancer
A PHASE III TWO-ARM RANDOMIZED STUDY COMPARING ANTIANDROGEN WITHDRAWAL ALONE VERSUS ANTIANDROGEN WITHDRAWAL COMBINED WITH KETOCONAZOLE AND HYDROCORTISON IN PATIENTS WITH ADVANCED PROSTAGE CANCER
Status: Enrolling
Updated: 6/27/2016
University of Minnesota Cancer Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
PROGNOSTIC SIGNIFICANCE OF ENDORECTAL MRI IN PREDICTING OUTCOME AFTER COMBINED RADIATION AND ANDROGEN SUPPRESSION FOR PROSTATE CANCER: A PROSPECTIVE PHASE II STUDY
Status: Enrolling
Updated:  6/27/2016
UCSF Cancer Center and Cancer Research Institute
mi
from
San Francisco, CA
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
PROGNOSTIC SIGNIFICANCE OF ENDORECTAL MRI IN PREDICTING OUTCOME AFTER COMBINED RADIATION AND ANDROGEN SUPPRESSION FOR PROSTATE CANCER: A PROSPECTIVE PHASE II STUDY
Status: Enrolling
Updated: 6/27/2016
UCSF Cancer Center and Cancer Research Institute
mi
from
San Francisco, CA
Click here to add this to my saved trials
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
PROGNOSTIC SIGNIFICANCE OF ENDORECTAL MRI IN PREDICTING OUTCOME AFTER COMBINED RADIATION AND ANDROGEN SUPPRESSION FOR PROSTATE CANCER: A PROSPECTIVE PHASE II STUDY
Status: Enrolling
Updated:  6/27/2016
Walter Reed Army Medical Center
mi
from
Washington,
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
PROGNOSTIC SIGNIFICANCE OF ENDORECTAL MRI IN PREDICTING OUTCOME AFTER COMBINED RADIATION AND ANDROGEN SUPPRESSION FOR PROSTATE CANCER: A PROSPECTIVE PHASE II STUDY
Status: Enrolling
Updated: 6/27/2016
Walter Reed Army Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
PROGNOSTIC SIGNIFICANCE OF ENDORECTAL MRI IN PREDICTING OUTCOME AFTER COMBINED RADIATION AND ANDROGEN SUPPRESSION FOR PROSTATE CANCER: A PROSPECTIVE PHASE II STUDY
Status: Enrolling
Updated:  6/27/2016
University of Chicago Cancer Research Center
mi
from
Chicago, IL
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
PROGNOSTIC SIGNIFICANCE OF ENDORECTAL MRI IN PREDICTING OUTCOME AFTER COMBINED RADIATION AND ANDROGEN SUPPRESSION FOR PROSTATE CANCER: A PROSPECTIVE PHASE II STUDY
Status: Enrolling
Updated: 6/27/2016
University of Chicago Cancer Research Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
PROGNOSTIC SIGNIFICANCE OF ENDORECTAL MRI IN PREDICTING OUTCOME AFTER COMBINED RADIATION AND ANDROGEN SUPPRESSION FOR PROSTATE CANCER: A PROSPECTIVE PHASE II STUDY
Status: Enrolling
Updated:  6/27/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
PROGNOSTIC SIGNIFICANCE OF ENDORECTAL MRI IN PREDICTING OUTCOME AFTER COMBINED RADIATION AND ANDROGEN SUPPRESSION FOR PROSTATE CANCER: A PROSPECTIVE PHASE II STUDY
Status: Enrolling
Updated: 6/27/2016
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
PROGNOSTIC SIGNIFICANCE OF ENDORECTAL MRI IN PREDICTING OUTCOME AFTER COMBINED RADIATION AND ANDROGEN SUPPRESSION FOR PROSTATE CANCER: A PROSPECTIVE PHASE II STUDY
Status: Enrolling
Updated:  6/27/2016
Joint Center for Radiation Therapy
mi
from
Boston, MA
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
PROGNOSTIC SIGNIFICANCE OF ENDORECTAL MRI IN PREDICTING OUTCOME AFTER COMBINED RADIATION AND ANDROGEN SUPPRESSION FOR PROSTATE CANCER: A PROSPECTIVE PHASE II STUDY
Status: Enrolling
Updated: 6/27/2016
Joint Center for Radiation Therapy
mi
from
Boston, MA
Click here to add this to my saved trials
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
PROGNOSTIC SIGNIFICANCE OF ENDORECTAL MRI IN PREDICTING OUTCOME AFTER COMBINED RADIATION AND ANDROGEN SUPPRESSION FOR PROSTATE CANCER: A PROSPECTIVE PHASE II STUDY
Status: Enrolling
Updated:  6/27/2016
St. Joseph's Hospital and Medical Center
mi
from
Paterson, NJ
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
PROGNOSTIC SIGNIFICANCE OF ENDORECTAL MRI IN PREDICTING OUTCOME AFTER COMBINED RADIATION AND ANDROGEN SUPPRESSION FOR PROSTATE CANCER: A PROSPECTIVE PHASE II STUDY
Status: Enrolling
Updated: 6/27/2016
St. Joseph's Hospital and Medical Center
mi
from
Paterson, NJ
Click here to add this to my saved trials
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
PROGNOSTIC SIGNIFICANCE OF ENDORECTAL MRI IN PREDICTING OUTCOME AFTER COMBINED RADIATION AND ANDROGEN SUPPRESSION FOR PROSTATE CANCER: A PROSPECTIVE PHASE II STUDY
Status: Enrolling
Updated:  6/27/2016
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
PROGNOSTIC SIGNIFICANCE OF ENDORECTAL MRI IN PREDICTING OUTCOME AFTER COMBINED RADIATION AND ANDROGEN SUPPRESSION FOR PROSTATE CANCER: A PROSPECTIVE PHASE II STUDY
Status: Enrolling
Updated: 6/27/2016
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
PROGNOSTIC SIGNIFICANCE OF ENDORECTAL MRI IN PREDICTING OUTCOME AFTER COMBINED RADIATION AND ANDROGEN SUPPRESSION FOR PROSTATE CANCER: A PROSPECTIVE PHASE II STUDY
Status: Enrolling
Updated:  6/27/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
PROGNOSTIC SIGNIFICANCE OF ENDORECTAL MRI IN PREDICTING OUTCOME AFTER COMBINED RADIATION AND ANDROGEN SUPPRESSION FOR PROSTATE CANCER: A PROSPECTIVE PHASE II STUDY
Status: Enrolling
Updated: 6/27/2016
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
PROGNOSTIC SIGNIFICANCE OF ENDORECTAL MRI IN PREDICTING OUTCOME AFTER COMBINED RADIATION AND ANDROGEN SUPPRESSION FOR PROSTATE CANCER: A PROSPECTIVE PHASE II STUDY
Status: Enrolling
Updated:  6/27/2016
Duke Comprehensive Cancer Center
mi
from
Durham, NC
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
PROGNOSTIC SIGNIFICANCE OF ENDORECTAL MRI IN PREDICTING OUTCOME AFTER COMBINED RADIATION AND ANDROGEN SUPPRESSION FOR PROSTATE CANCER: A PROSPECTIVE PHASE II STUDY
Status: Enrolling
Updated: 6/27/2016
Duke Comprehensive Cancer Center
mi
from
Durham, NC
Click here to add this to my saved trials
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
PROGNOSTIC SIGNIFICANCE OF ENDORECTAL MRI IN PREDICTING OUTCOME AFTER COMBINED RADIATION AND ANDROGEN SUPPRESSION FOR PROSTATE CANCER: A PROSPECTIVE PHASE II STUDY
Status: Enrolling
Updated:  6/27/2016
Comprehensive Cancer Center of Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
PROGNOSTIC SIGNIFICANCE OF ENDORECTAL MRI IN PREDICTING OUTCOME AFTER COMBINED RADIATION AND ANDROGEN SUPPRESSION FOR PROSTATE CANCER: A PROSPECTIVE PHASE II STUDY
Status: Enrolling
Updated: 6/27/2016
Comprehensive Cancer Center of Wake Forest University Baptist Medical Center
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
PROGNOSTIC SIGNIFICANCE OF ENDORECTAL MRI IN PREDICTING OUTCOME AFTER COMBINED RADIATION AND ANDROGEN SUPPRESSION FOR PROSTATE CANCER: A PROSPECTIVE PHASE II STUDY
Status: Enrolling
Updated:  6/27/2016
Arthur G. James Cancer Hospital - Ohio State University
mi
from
Columbus, OH
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
PROGNOSTIC SIGNIFICANCE OF ENDORECTAL MRI IN PREDICTING OUTCOME AFTER COMBINED RADIATION AND ANDROGEN SUPPRESSION FOR PROSTATE CANCER: A PROSPECTIVE PHASE II STUDY
Status: Enrolling
Updated: 6/27/2016
Arthur G. James Cancer Hospital - Ohio State University
mi
from
Columbus, OH
Click here to add this to my saved trials
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
PROGNOSTIC SIGNIFICANCE OF ENDORECTAL MRI IN PREDICTING OUTCOME AFTER COMBINED RADIATION AND ANDROGEN SUPPRESSION FOR PROSTATE CANCER: A PROSPECTIVE PHASE II STUDY
Status: Enrolling
Updated:  6/27/2016
Medical University of South Carolina
mi
from
Charleston, SC
Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer
PROGNOSTIC SIGNIFICANCE OF ENDORECTAL MRI IN PREDICTING OUTCOME AFTER COMBINED RADIATION AND ANDROGEN SUPPRESSION FOR PROSTATE CANCER: A PROSPECTIVE PHASE II STUDY
Status: Enrolling
Updated: 6/27/2016
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
University of California San Diego Cancer Center
mi
from
La Jolla, CA
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
University of California San Diego Cancer Center
mi
from
La Jolla, CA
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
UCSF Cancer Center and Cancer Research Institute
mi
from
San Francisco, CA
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
UCSF Cancer Center and Cancer Research Institute
mi
from
San Francisco, CA
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
CCOP - Christiana Care Health Services
mi
from
Wilmington, DE
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
CCOP - Christiana Care Health Services
mi
from
Wilmington, DE
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
Walter Reed Army Medical Center
mi
from
Washington,
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
Walter Reed Army Medical Center
mi
from
Washington,
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
Mount Sinai Medical Center CCOP
mi
from
Miami Beach, FL
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
Mount Sinai Medical Center CCOP
mi
from
Miami Beach, FL
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
University of Illinois at Chicago Health Sciences Center
mi
from
Chicago, IL
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
University of Illinois at Chicago Health Sciences Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated:  6/27/2016
University of Chicago Cancer Research Center
mi
from
Chicago, IL
Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors
A Pilot Study of Low-Dose Interleukin-2 Plus Recombinant Human Anti-HER2 Monoclonal Antibody in Solid Tumors
Status: Enrolling
Updated: 6/27/2016
University of Chicago Cancer Research Center
mi
from
Chicago, IL
Click here to add this to my saved trials